SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Portfolio Acquisition

7 Aug 2013 12:41

RNS Number : 1092L
Caledonia Investments PLC
07 August 2013
 



 

 

Caledonia Investments plc

 

 

 

CALEDONIA INVESTMENTS PLC ACQUIRES THE CARE HOMES OPERATOR, CHOICE CARE GROUP

 

Caledonia Investments plc ("Caledonia") is pleased to announce that it has acquired Choice Holdings Ltd, Truecare Holdings Ltd and Choice Pathways Ltd (together "Choice Care Group" or "Choice" or the "Group") from Sovereign Capital in a transaction which values the business at £86 million. Choice Care Group provides support services for adults with learning disabilities, mental health disorders or complex needs through a portfolio of 47 residential care homes, owned and operated in the South of England.

 

Caledonia has subscribed £49.5 million in cash at completion for an initial 97.7% stake, the balance of the equity being rolled over by the management team led by Chief Executive, Edwina Johnston. The Royal Bank of Scotland plc, AIB Group (UK) plc and Santander UK plc (together "the Banks") have provided £40 million of senior debt financing. Both Caledonia and the Banks have committed to provide additional capital to fund the future development of Choice supporting management's growth plans for the Group.

 

Edwina Johnston has led Choice since 2009 as CEO and was previously the Group's CFO from 2002. She has overseen the development of Choice into the leading care business it is today. Choice places the delivery of care at the heart of its business model seeking to deliver positive care outcomes for its service users at all times. Choice enjoys 100% CQC compliance.

 

For the financial year to 30 September 2012, Choice Care Group generated EBITDA of £8.9 million, made combined profit before tax of £3.2 million and had gross assets of £45.8 million. From the outset, Choice will pay a running yield to Caledonia that is forecast to build over the life of the investment.

 

Commenting on the acquisition, Duncan Johnson, Caledonia's Head of Unquoted Investments, said:

 

"We are delighted to back Edwina Johnston and her management team in the buy-out of Choice. The group is recognised as a premium asset in the learning disability sector providing exceptional levels of care for its service users. Choice's estate is well invested and represents a solid platform for growth.

 

We look forward to a rewarding relationship with Edwina, Choice and its service users in the years ahead."

 

Edwina Johnston commented:

 

"It is great to have the backing of Caledonia and their long term support for our continuing investment plans. Under their ownership we can continue our expansion plans, adding new homes across the South, as well as maintain our continuous improvement plans across our portfolio ensuring we maintain our reputation for the very highest standards of care for our service users."

 

 

Will Wyatt, CEO of Caledonia commented:

 

"Our investment in Choice represents another positive step in the development of Caledonia's unquoted investment business, building upon our reputation as a measured, long-term investor in the unquoted arena. Choice fits well with the investment criteria we have set out to shareholders and I am confident it will deliver positive returns from the continuing growth of the business."

 

7 August 2013

For further information contact:

 

 

Caledonia Investments plc

 

Will Wyatt,

Chief Executive

+44 20 7802 8080

Duncan Johnson,

Head of Unquoted Investments

 

 

 

Media contact:

 

 

 

Tulchan Communications

 

Peter Hewer

+44 20 7353 4200

Katerina Soumilova

 

 

END

 

 

Notes for editors:

 

Caledonia Investments plc

 

Caledonia is a self-managed investment trust company listed on the London Stock Exchange with net assets of approximately £1.3bn. The company maintains a concentrated portfolio of international quoted, unquoted and fund investments and has paid an increasing dividend for 45 years.

 

In the unquoted arena, Caledonia seeks to invest £20 to £50 million in private companies either on a majority or minority basis in situations where it believes there to be a good opportunity for building value over the longer term.

 

For additional information on Caledonia, please visit www.caledonia.com. Neither the contents of the company's website nor the contents of any website accessible from hyperlinks on the company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

 

Choice Care Group

 

Choice is headquartered in Reading, Berkshire and operates in the surrounding regions. The business owns and operates 47 residential care homes for people with Learning Disabilities or mental health disorders. In addition, through its subsidiary, Excel Support Services, the Group provides supported living services for additional service users in the same areas.

 

Choice employs in excess of 1,200 employees throughout the business.

 

Choice's strategy is to develop additional homes in its current areas of geographical focus as well as entering adjoining counties via new home development. Choice's business model and measured growth plans result in the delivery of care being placed at the heart of the business.

 

For additional information on Choice, please visit www.choicecaregroup.com. Neither the contents of the company's website nor the contents of any website accessible from hyperlinks on the company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

 

Transaction

 

The transaction was led by Charlie Edwards, Duncan Johnson and Sally Flanagan on behalf of Caledonia. Caledonia was advised by Osborne Clark (Mark Spinner and Ben Truman), DC Advisory (Richard Clark and Phillip Gutzwiller), Connell Consulting (Clare Connell), Deloittes (Tim Haden) and Catalysis (Mike Hicks). Insurance advice was provided by both JLT and Aon. PricewaterhouseCoopers (Jason Wakelam) provided financial due diligence advice.

 

Banking facilities to support the transaction have been provided by RBS, AIB and Santander. The transaction was led on behalf of the banks by Mark Ward (RBS) with advice from Hogan Lovells (Stuart Brinkworth).

 

The Management team was advised by Chris Spanoudakis from Equita Corporate Finance as well as by CMS Cameron McKenna.

 

Sovereign Capital was advised by Jefferies International and CMS Cameron McKenna.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUGUBWRUPWGGM
Date   Source Headline
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20229:22 amRNSNet Asset Value(s)
22nd Nov 20227:00 amRNSDirectorate Change
22nd Nov 20227:00 amRNSHalf-year Report
7th Nov 202210:49 amRNSNet Asset Value(s)
7th Oct 20227:00 amRNSUnaudited net asset value and portfolio update
30th Sep 20224:21 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:51 pmRNSDirector/PDMR Shareholding
6th Sep 202210:17 amRNSNet Asset Value(s)
23rd Aug 20225:21 pmRNSDirector/PDMR Shareholding
15th Aug 20222:21 pmRNSDirector Declaration
4th Aug 202212:41 pmRNSNet Asset Value(s)
27th Jul 20224:47 pmRNSResult of AGM
19th Jul 20224:59 pmRNSDirector Declaration
7th Jul 20227:00 amRNSUnaudited net asset value and portfolio update
23rd Jun 20224:00 pmRNSAnnual Financial Report
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
16th Jun 20224:32 pmRNSDirector/PDMR Shareholding
14th Jun 20221:51 pmRNSDirector/PDMR Shareholding
8th Jun 20229:36 amRNSNet Asset Value(s)
6th Jun 20223:33 pmRNSDirector/PDMR Shareholding
31st May 20224:50 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSFinal Results
6th May 20229:02 amRNSNet Asset Value(s)
7th Apr 20227:00 amRNSUnaudited net asset value and portfolio update
4th Apr 202210:10 amRNSDirectorate Change
25th Mar 20224:47 pmRNSDirector/PDMR Shareholding
21st Mar 20223:56 pmRNSDirector/PDMR Shareholding
16th Mar 20222:05 pmRNSDirector/PDMR Shareholding
7th Mar 20227:00 amRNSDirectorate Change
7th Mar 20227:00 amRNSNet Asset Value(s)
28th Feb 20224:59 pmRNSTotal Voting Rights
4th Feb 20224:56 pmRNSTransaction in Own Shares
4th Feb 20229:52 amRNSNet Asset Value(s)
31st Jan 20225:23 pmRNSTotal Voting Rights
28th Jan 20225:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.